|
Market Closed -
Other stock markets
|
Pre-market 13:28:12 | |||
| 26.90 USD | +0.34% |
|
27.12 | +0.84% |
| 01:31pm | Barclays Adjusts Campbell's Price Target to $27 From $30, Maintains Underweight Rating | MT |
| 12:36pm | Morgan Stanley Lowers Price Target on Campbell's to $28 From $30, Keeps Equalweight Rating | MT |
| Fiscal Period: August | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.15 | 6.32 | 7.4 | 6.41 | 6.12 | |||||
Return on Total Capital | 11.25 | 8.87 | 10.41 | 8.76 | 8.22 | |||||
Return On Equity % | 35.23 | 23.34 | 24.53 | 15.2 | 15.64 | |||||
Return on Common Equity | 35.28 | 23.35 | 24.54 | 15.21 | 15.64 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 33.2 | 30.74 | 31.37 | 31.31 | 30.73 | |||||
SG&A Margin | 16.35 | 15.53 | 15.2 | 15.06 | 14.88 | |||||
EBITDA Margin % | 22.29 | 17.88 | 19.2 | 18.5 | 18.43 | |||||
EBITA Margin % | 19.04 | 14.42 | 15.58 | 15 | 14.86 | |||||
EBIT Margin % | 18.55 | 13.95 | 15.14 | 14.52 | 14.4 | |||||
Income From Continuing Operations Margin % | 11.89 | 8.84 | 9.17 | 5.88 | 5.87 | |||||
Net Income Margin % | 11.82 | 8.84 | 9.17 | 5.88 | 5.87 | |||||
Net Avail. For Common Margin % | 11.89 | 8.84 | 9.17 | 5.88 | 5.87 | |||||
Normalized Net Income Margin | 10.04 | 7.34 | 8.24 | 7.5 | 7 | |||||
Levered Free Cash Flow Margin | 9 | 9.95 | 8.28 | 5.99 | 7.01 | |||||
Unlevered Free Cash Flow Margin | 10.55 | 11.33 | 9.54 | 7.6 | 9.11 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.7 | 0.72 | 0.78 | 0.71 | 0.68 | |||||
Fixed Assets Turnover | 3.24 | 3.3 | 3.56 | 3.38 | 3.35 | |||||
Receivables Turnover (Average Receivables) | 15.78 | 16.56 | 19.02 | 17.83 | 18.18 | |||||
Inventory Turnover (Average Inventory) | 6.28 | 5.44 | 5.06 | 4.95 | 5.05 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.93 | 0.68 | 0.93 | 0.61 | 0.77 | |||||
Quick Ratio | 0.37 | 0.23 | 0.32 | 0.21 | 0.25 | |||||
Operating Cash Flow to Current Liabilities | 0.57 | 0.41 | 0.51 | 0.33 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 23.06 | 21.98 | 19.14 | 20.42 | 20.41 | |||||
Days Outstanding Inventory (Average Inventory) | 57.99 | 66.88 | 71.9 | 73.61 | 73.4 | |||||
Average Days Payable Outstanding | 67.38 | 70.08 | 74.3 | 70.94 | 68.67 | |||||
Cash Conversion Cycle (Average Days) | 13.67 | 18.77 | 16.74 | 23.08 | 25.14 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 167.79 | 151.49 | 135.6 | 198.68 | 184.73 | |||||
Total Debt / Total Capital | 62.66 | 60.24 | 57.56 | 66.52 | 64.88 | |||||
LT Debt/Equity | 164.55 | 125.2 | 128.47 | 158.82 | 162.76 | |||||
Long-Term Debt / Total Capital | 61.45 | 49.79 | 54.53 | 53.18 | 57.16 | |||||
Total Liabilities / Total Assets | 73.12 | 71.97 | 69.62 | 75.08 | 73.79 | |||||
EBIT / Interest Expense | 7.49 | 6.32 | 7.54 | 5.62 | 4.28 | |||||
EBITDA / Interest Expense | 10.55 | 9.59 | 11.46 | 8.7 | 6.76 | |||||
(EBITDA - Capex) / Interest Expense | 9.24 | 8.31 | 9.49 | 6.63 | 5.52 | |||||
Total Debt / EBITDA | 2.39 | 2.79 | 2.31 | 3.48 | 3.09 | |||||
Net Debt / EBITDA | 2.36 | 2.73 | 2.22 | 3.43 | 3.04 | |||||
Total Debt / (EBITDA - Capex) | 2.73 | 3.22 | 2.78 | 4.57 | 3.79 | |||||
Net Debt / (EBITDA - Capex) | 2.69 | 3.15 | 2.68 | 4.51 | 3.72 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.47 | 1.01 | 9.29 | 2.98 | 6.4 | |||||
Gross Profit, 1 Yr. Growth % | -6.45 | -6.47 | 11.51 | 2.79 | 4.44 | |||||
EBITDA, 1 Yr. Growth % | 13.66 | -20.51 | 17.37 | -0.78 | 6 | |||||
EBITA, 1 Yr. Growth % | 17.21 | -25.2 | 18.06 | -0.89 | 5.47 | |||||
EBIT, 1 Yr. Growth % | 17.84 | -25.79 | 18.68 | -1.27 | 5.5 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 70.27 | -24.9 | 13.34 | -33.92 | 6.17 | |||||
Net Income, 1 Yr. Growth % | -38.45 | -24.45 | 13.34 | -33.92 | 6.17 | |||||
Normalized Net Income, 1 Yr. Growth % | 37.44 | -28.14 | 22.56 | -6.24 | -0.69 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 69.23 | -23.94 | 13.55 | -33.68 | 6.35 | |||||
Accounts Receivable, 1 Yr. Growth % | 2.64 | -9.93 | 0.82 | 18.83 | -7.84 | |||||
Inventory, 1 Yr. Growth % | 7.12 | 33.55 | 3.61 | 7.36 | 2.74 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.65 | -0.88 | 3.52 | 13.39 | 2.05 | |||||
Total Assets, 1 Yr. Growth % | -5.16 | 1.35 | 1.4 | 26.35 | -2.23 | |||||
Tangible Book Value, 1 Yr. Growth % | -14.77 | -5.46 | -10.4 | 74.09 | -9.23 | |||||
Common Equity, 1 Yr. Growth % | 22.98 | 5.68 | 9.91 | 3.63 | 2.85 | |||||
Cash From Operations, 1 Yr. Growth % | -25.86 | 14.11 | -3.22 | 3.67 | -4.56 | |||||
Capital Expenditures, 1 Yr. Growth % | -8.03 | -12 | 52.89 | 39.73 | -17.6 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -15.95 | 8.36 | -8.93 | -25.59 | 24.64 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -20.4 | 5.73 | -7.91 | -17.95 | 27.6 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.29 | 1.37 | 0 | 0 | 4.05 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.25 | -0.74 | 5.07 | 6.09 | 4.68 | |||||
Gross Profit, 2 Yr. CAGR % | 1.88 | -6.46 | 2.13 | 7.06 | 3.61 | |||||
EBITDA, 2 Yr. CAGR % | 11.92 | -2.7 | -3.41 | 7.92 | 2.96 | |||||
EBITA, 2 Yr. CAGR % | 16.31 | -3.71 | -6.03 | 8.17 | 2.73 | |||||
EBIT, 2 Yr. CAGR % | 17.17 | -3.76 | -6.16 | 8.24 | 2.57 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 45.83 | 13.08 | -7.74 | -13.45 | -16.24 | |||||
Net Income, 2 Yr. CAGR % | 117.92 | -31.81 | -7.46 | -13.45 | -16.24 | |||||
Normalized Net Income, 2 Yr. CAGR % | 31.22 | 3.01 | -6.15 | 7.2 | -2.96 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 44.98 | 13.45 | -7.07 | -13.23 | -16.02 | |||||
Accounts Receivable, 2 Yr. CAGR % | 1.79 | -3.85 | -4.71 | 9.45 | 4.65 | |||||
Inventory, 2 Yr. CAGR % | 3.98 | 19.61 | 17.63 | 5.47 | 5.02 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.01 | -0.77 | 1.3 | 8.35 | 7.57 | |||||
Total Assets, 2 Yr. CAGR % | -5.53 | -1.96 | 1.37 | 13.19 | 11.15 | |||||
Tangible Book Value, 2 Yr. CAGR % | -19.83 | -10.23 | -7.96 | 24.89 | 25.7 | |||||
Common Equity, 2 Yr. CAGR % | 69.05 | 14 | 7.77 | 6.72 | 3.24 | |||||
Cash From Operations, 2 Yr. CAGR % | -9.01 | -8.02 | 5.09 | 0.17 | -0.53 | |||||
Capital Expenditures, 2 Yr. CAGR % | -15.37 | -10.04 | 15.99 | 46.16 | 7.3 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -0.96 | -1.6 | -0.72 | -17.68 | -3.15 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -5.45 | -5.9 | -1.37 | -13.07 | 2.82 | |||||
Dividend Per Share, 2 Yr. CAGR % | 2.12 | 2.82 | 0.68 | 0 | 2.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.61 | 1.84 | 2.49 | 4.37 | 6.19 | |||||
Gross Profit, 3 Yr. CAGR % | 4.57 | -0.98 | -0.82 | 2.35 | 6.18 | |||||
EBITDA, 3 Yr. CAGR % | 3.92 | 0.51 | 3.58 | -2.54 | 7.27 | |||||
EBITA, 3 Yr. CAGR % | 4.26 | 1.16 | 3.06 | -4.35 | 7.26 | |||||
EBIT, 3 Yr. CAGR % | 3.84 | 1.41 | 3.21 | -4.55 | 7.32 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.66 | 16.89 | 13.17 | -17.45 | -7.35 | |||||
Net Income, 3 Yr. CAGR % | 56.58 | 53.09 | -19.22 | -17.29 | -7.35 | |||||
Normalized Net Income, 3 Yr. CAGR % | 3.6 | 8.34 | 9.16 | -6.18 | 4.5 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 11.2 | 16.93 | 13.48 | -16.95 | -7.14 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.17 | -2.27 | -2.32 | 2.57 | 3.36 | |||||
Inventory, 3 Yr. CAGR % | 1.7 | 13.02 | 14.02 | 14.1 | 4.55 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.84 | 1.7 | 0.64 | 5.18 | 6.2 | |||||
Total Assets, 3 Yr. CAGR % | -6.87 | -3.29 | -0.85 | 9.09 | 7.8 | |||||
Tangible Book Value, 3 Yr. CAGR % | -12.94 | -15.3 | -10.29 | 13.82 | 12.29 | |||||
Common Equity, 3 Yr. CAGR % | 32.21 | 44.54 | 12.62 | 6.37 | 5.42 | |||||
Cash From Operations, 3 Yr. CAGR % | -9.79 | -1.87 | -6.45 | 4.61 | -1.43 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12.25 | -14.26 | 7.36 | 23.42 | 20.74 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 0.01 | 3.07 | -4.14 | -9.82 | -5.47 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 0.64 | -1.02 | -6.6 | -7.24 | -1.21 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.41 | 1.87 | 1.87 | 0.45 | 1.33 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.26 | 7.96 | 7.18 | 3.52 | 3.36 | |||||
Gross Profit, 5 Yr. CAGR % | -0.79 | 1.48 | 3.59 | 2.16 | 0.93 | |||||
EBITDA, 5 Yr. CAGR % | 5.32 | -2.03 | 1.32 | 3.41 | 3.17 | |||||
EBITA, 5 Yr. CAGR % | 6.65 | -3.86 | 0.47 | 3.91 | 2.73 | |||||
EBIT, 5 Yr. CAGR % | 6.45 | -4.5 | 0.18 | 4.09 | 2.75 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.35 | -3.91 | 3.45 | 3.65 | 0.34 | |||||
Net Income, 5 Yr. CAGR % | 12.22 | -3.12 | 26.87 | 21.86 | -18.04 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.54 | -6.03 | 0.13 | 7.88 | 3.9 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.76 | -3.57 | 3.5 | 3.78 | 0.61 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.36 | -2.28 | -0.64 | 2.26 | 0.41 | |||||
Inventory, 5 Yr. CAGR % | -0.15 | 6.67 | 7.8 | 9.94 | 10.33 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.59 | 1.02 | 1.63 | 4.31 | 3.36 | |||||
Total Assets, 5 Yr. CAGR % | 8.41 | 9.01 | -3.66 | 2.99 | 3.78 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.57 | 19.23 | -10.98 | -1.07 | 2.67 | |||||
Common Equity, 5 Yr. CAGR % | 15.63 | 15.27 | 21.83 | 28.03 | 8.77 | |||||
Cash From Operations, 5 Yr. CAGR % | -7.04 | -0.91 | -4.11 | -1.06 | -4.12 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.21 | -6.46 | -1.89 | 6.13 | 7.34 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -4.85 | 0.93 | 0.31 | -5.81 | -3.96 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -3.17 | 1.85 | 0.34 | -6.05 | -3.13 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.19 | 1.12 | 1.12 | 1.12 | 1.92 |
- Stock Market
- Equities
- CPB Stock
- Financials The Campbell's Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















